Sociodemographic data, disease outcomes, and comorbidity sample characteristics.
| Variables | Values |
|---|---|
| Sociodemographic | |
| Age, yrs | 45.4 ± 10.7 |
| Sex, male | 233 (49.1) |
| Having a partner, n = 444 | 386 (86.9) |
| Education level, university | 185 (39.0) |
| Job status, employee | 234 (49.4) |
| Patient association membership | 227 (47.8) |
| Disease outcomes | |
| BASDAI (0–10), n = 442 | 5.4 ± 2.1 |
| Spinal stiffness, moderate or severe | |
| Cervical (1–4), n = 447 | 201 (44.9) |
| Thoracic (1–4), n = 435 | 186 (42.7) |
| Lumbar (1–4), n = 458 | 288 (62.8) |
| Functional limitations in daily activities (0–54), n = 473 | 27.5 ± 12.7 |
| Treatment | |
| NSAID | 363 (76.6) |
| sDMARD | 181 (38.2) |
| bDMARD | 240 (50.3) |
| Comorbidity | |
| Self-reported depression diagnostic | 99 (20.8) |
| Self-reported anxiety diagnostic | 134 (28.2) |
| GHQ-12 score (0–36) | 18.3 ± 8.0 |
N = 474 unless otherwise specified. Results are expressed as mean ± SD or n (%). BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; NSAID: nonsteroidal antiinflammatory drug; sDMARD: synthetic disease-modifying antirheumatic drug; bDMARD: biological DMARD; GHQ-12: 12-item General Health Questionnaire.